Overview
Hodgkin's disease, mixed cellularity subtype, is a type of lymphoma characterized by the presence of Reed-Sternberg cells alongside a mixed population of inflammatory cells, primarily lymphocytes and histiocytes. It typically affects lymph nodes but can involve extranodal sites 1.Diagnosis
Key Diagnostic Criteria: Presence of Reed-Sternberg cells with mixed cellularity in biopsy samples 1.
Recommended Tests: Histopathological examination with immunohistochemistry, flow cytometry for immunophenotyping 2.
Grading: Not specifically detailed in provided abstracts; typically assessed using the Ann Arbor staging system 1.Management
First-Line Treatment: Chemotherapy regimens such as ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine) 1.
Adjunctive Treatments: Radiation therapy for localized disease, stem cell transplantation for advanced stages 1.
Monitoring: Regular laboratory assessments using multiple paired samples to detect changes in clinical status accurately 1.Special Populations
Pregnancy: Specific management guidelines not covered in provided abstracts 1.
Pediatrics: No specific details provided in the abstracts 1.
Elderly: Considerations for treatment intensity and potential comorbidities not detailed 1.
Comorbidities: Impact on treatment selection and monitoring strategies not explicitly addressed 1.Key Recommendations
Utilize multiple paired laboratory samples for monitoring to improve detection of clinically significant changes in patients with Hodgkin's disease, mixed cellularity subtype (Evidence: Moderate) 1.
Employ clinical flow cytometry for accurate immunophenotyping in diagnosis and monitoring (Evidence: Moderate) 2.
Consider the cost implications of frequent testing, recognizing that reducing sample requests may not proportionally decrease overall laboratory costs (Evidence: Weak) 3.References
1 Kroll MH. Multiple patient samples of an analyte improve detection of changes in clinical status. Archives of pathology & laboratory medicine 2010. link
2 McCoy JP, Keren DF. Current practices in clinical flow cytometry. A practice survey by the American Society of Clinical Pathologists. American journal of clinical pathology 1999. link
3 Leijten JF, van der Geer F, Scholten MN, Goldschmidt HM. The costing of tests in a laboratory for clinical chemistry and haematology. Annals of clinical biochemistry 1984. link